CliffBio
small molecule

DIURIL

CHLOROTHIAZIDE

Loss of exclusivity—loss of exclusivity
CompanySalix Pharmaceuticals →See this company's full patent-cliff portfolio

Drug detail

Brand nameDIURIL
Active ingredientCHLOROTHIAZIDE
Strength250MG/5ML
Dosage formSUSPENSION
RouteORAL
ModalitySmall molecule
Marketing statusDISCN

More from Salix Pharmaceuticals

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.